Patient’s Journey of Therapies for Multiple Sclerosis

Video

A patient shares the treatments she has received for multiple sclerosis.

June Halper, MSN, MSCN: Ann, when you first started your journey with MS [multiple sclerosis], were you put on a disease-modifying therapy? I think you mentioned 1989 and we know that was one of the early years before therapy started. I think it was 92, right, Dr. Coyle?

Patricia K. Coyle, MD: 1993 for interferon beta-1b.

June Halper, MSN, MSCN: 3, yeah.

Ann Moore: I was diagnosed in 1989 and I conferred with you and Dr. Geiser, and it was determined that I have MS. But, at that point, they had no therapies out. I have to be honest, I thought for the first 10 years they made an incorrect diagnosis. I was fine. I had nothing wrong with me. No numbness, no tingling, no weakness, no anything. And then 10 years later I’m like, “Oh, something’s not right here.” I was having a, unbeknownst to me, a thoracic exacerbation. I called over to the MS Center, at that point Dr. Cohn was there, went over to see you folks, and you said, “Annie, here are the therapies that are out. I know you; I would suggest that this is the one you go on, but I suggest that you also do some research on your own and see if you concur with me.” I was very happy at your suggestion and for 15 years I was on Copaxone and I thought it was a magnificent drug. I still think it’s a good drug. Just after 15 years it ran its course and I had to switch therapies.

June Halper, MSN, MSCN: I know Copaxone had minimal side effects, but the injection every day, how’d you handle that? 

Ann Moore: I went on, when you had the powder and you had to mix it with the solution and rub it between your hands.

June Halper, MSN, MSCN: Yeah. Remember that, Dr. Coyle?

Ann Moore: No auto injects or anything like that. Kathy had to do four of the injections because I couldn’t reach them. You know what, needles don’t bother me, so I did not have a problem in doing that. I mean, I do have divots in all seven locations right now and will for the rest of my life, but it’s OK.

June Halper, MSN, MSCN: Well, Kathy didn’t seem to mind. Right, Kathy?

Kathy Zelles: No. Never.

June Halper, MSN, MSCN: Are you on therapy now, Ann?

Ann Moore: I am on Rituxan. I had been on Rituxan now for a couple years, so, as a matter of fact, I go, I believe it’s in February, that I go for a Rituxan infusion. Yeah, Dr. Williams, the doctor that I go to right now at the International MS Center is very good because he can juggle. As he said, “Ann, I have a lot of cocktails.” I mean, over the years, yeah, I was on, but even before I went on Copaxone, I did IVIG for 10 months. I’ve done Tysabri a couple times. But for the last three or four years it’s been methotrexate injections and Rituxan.

June Halper, MSN, MSCN: Dr. Coyle, any comments about Ann’s therapy?

Patricia K. Coyle, MD: Well, rituximab [Rituxan] is a chimeric anti-CD20 monoclonal antibody therapy. It is not approved by the Food and Drug Administration (FDA) for MS but clearly has significant off-label use in Sweden. Kaiser Permanente, I understand it’s their go-to MS drug. It’s much cheaper. We have two FDA approved anti-CD20s, in humanized and human for MS, but rituximab is much cheaper. I think it’s a very reasonable alternative, high-efficacy agent, even though it’s never going to be approved for MS.

June Halper, MSN, MSCN: Well, it seems like your journey with MS and medications, Ann, has been an interesting one and it seems that.

Ann Moore: Yeah, I’ve gone through the gamut. 

June Halper, MSN, MSCN: You are very proactive. 

Ann Moore: Yeah. I am my mother’s daughter. My mother had this, we would have put it on her headstone if we could have, “Can do.” I can do it and that’s how I feel.

June Halper, MSN, MSCN: Where was she born?

Ann Moore: Well, she was born in New York City.

June Halper, MSN, MSCN: So, there you go.

Ann Moore: Absolutely. 

June Halper, MSN, MSCN: Right, Dr. Coyle, Dr. Foley, right? The New Yorkers …

Patricia K. Coyle, MD: Can do.

June Halper, MSN, MSCN: I want to thank you all for watching and joining us at this NeurologyLive® Cure Connections®. If you enjoyed this program, please subscribe to the e-newsletter to receive upcoming information about other programs. I’d like to thank you all for the time and I thank you all for this wonderful opportunity and hope to see you all again.


Related Videos
Amanda Peltier, MD
Marjan Gharagozloo, PhD
 Jeffrey Huang, PhD
Shiv Saidha, MBBCh
Julie Fiol, MSCN; Andreina Barnola, MD, MPH
Amaal Starling, MD, FAHS, FAAN
Lars Alfredsson, PhD
Jenn Orthmann-Murphy, MD, PhD
Amit Bar-Or, MD, FRCPC, FAAN, FANA
© 2024 MJH Life Sciences

All rights reserved.